DYNPORT VACCINE COMPANY LLC

DYNPORT VACCINE COMPANY LLC specializes in preclinical and clinical-stage biotechnology research and development, with deep expertise in vaccine and biological product development, early-phase clinical trial execution, and stability testing of therapeutic candidates. The company delivers end-to-end scientific support for life science programs, including protocol design, regulatory-enabling studies, and manufacturing process validation for biological products. Their technical proficiency spans immunology, bioprocess development, and regulatory compliance pathways for FDA licensure, with demonstrated experience in advancing bioscavengers and prophylactic biologics through Phase I trials. A key differentiator is their ability to integrate complex research objectives with stringent federal regulatory requirements, ensuring robust data packages for product approval. The contractor maintains a strong, long-standing relationship with the Department of Health and Human Services, particularly supporting agencies involved in biomedical advanced research and development, where they execute early-phase clinical trial units and biotechnology R&D initiatives. They also deliver specialized scientific services to the Department of Defense, focusing on defense-relevant medical countermeasures, including stability and shelf-life characterization of biological therapeutics under operational conditions. Their primary industry focus lies in biotechnology R&D and biological product manufacturing, aligning with the development of novel vaccines, therapeutics, and prophylactic agents. This positions them as a niche provider in the federal biodefense and public health preparedness market, bridging laboratory innovation with scalable production and regulatory submission readiness. DYNPORT VACCINE COMPANY LLC is a small business entity headquartered in Frederick, Maryland, with no formal government certifications on record. Their geographic location places them within a major biopharmaceutical corridor, enabling proximity to federal research institutions and regulatory bodies. The company operates as a specialized contractor serving mission-critical government health and defense programs without public commercial offerings.